Clinical Trial Update: Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating PolaR-ICE (polatuzumab vedotin, rituximab, ifosfamide, carboplatin, etoposide) as initial salvage therapy for relapsed/refractory diffu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Diffuse Large B-cell Lymphoma Unclassifiable
• Mediastinal Large B-cell Lymphoma
• Transformed B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Ifex (ifosfamide)
• Paraplatin (Carboplatin)
• Polivy (polatuzumab vedotin)
• Rituxan (rituximab)
• Toposar (Etoposide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Diffuse Large B-Cell Lymphoma Unclassifiable, Recurrent Diffuse Large B-Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-08-26